What Is My Dental Practice Worth? How Buyers Value It
A plain-English valuation guide for owners of $5M–$200M dental practices — what a DSO or PE buyer actually pays, and the levers that move your multiple by two to four full turns.
Updated 2026-06-12·Updated 2026 · 12 min read·Healthcare Services & IT
Typical multiple
5x – 11x
Priced on Adjusted EBITDA · Typical 7.5x
Triangulated from FOCUS Investment Banking 2026 ranges, Sorso 2026, and Large Practice Sales 2024 outcomes (6.75x–11.25x); high end reflects DSO/consolidator platform premiums requiring multi-location scale; solo owner-dependent practice priced on SDE or % of collections sits below this band
- Associate-adjusted EBITDA multiple
- 5x – 11x
- Typical associate-adjusted EBITDA margin
- 18–28%
- LMM group midpoint
- 7.5x
- Basis pivot at ~$2M value
- SDE → EBITDA
The short answer
A lower-middle-market dental group is worth a multiple of its associate-adjusted normalized earnings, not its collections. In 2026, LMM dental practices and groups sell at 5x to 11x associate-adjusted EBITDA (roughly 7.5x midpoint for a clean multi-provider group), while solo owner-operated practices under ~$500K of post-doctor-comp earnings typically price on SDE or a percentage of annual collections.[1][9] The high end reflects DSO-consolidator and platform-recap premiums that require multi-location scale and associate-led production — a single owner-dependent practice sits materially lower.[1][2] Per IBISWorld, the US dentist market is highly fragmented with 179,584 businesses and no single operator holding more than 5% market share, creating a long runway for DSO consolidation.[8]
Estimate vs. reality
A calculator estimate is not what a buyer pays
Type your collections or earnings into a free online calculator and you will see a revenue multiple or a single EBITDA estimate. That is a starting point at best. A DSO or PE buyer prices your practice against real comps, validates your earnings in a quality-of-earnings review, and applies a multiple calibrated to your specific size band, provider mix, and payor profile — a gap that routinely moves value 20–50% in either direction.[13][14]
- Collections or earnings × a generic dental multiple or industry rule of thumb
- One point estimate with no size-band segmentation (add-on vs. platform multiples differ by 3–5 turns)
- No associate adjustment — owner-doctor clinical pay is not normalized to a market rate
- No view of deal structure: cash at close, rollover equity, earn-out, or working-capital peg
- Associate-adjusted EBITDA — owner-doctor production normalized to a market clinical wage before the multiple is applied
- A multiple set by your size band: ~5–8x for a DSO add-on, ~9–11x for a regional platform
- Provider transferability: how much production walks out the door with the seller
- Payor mix quality: commercial PPO/FFS vs. Medicaid/HMO concentration and state-policy risk
- A structured price — typically 60–75% cash at close, 15–30% rollover equity, 5–15% earn-out
In owner-operated dental practices, reported EBITDA commonly overstates the buyer's number because the owner-dentist's clinical wage has not been deducted — skipping the associate adjustment can inflate apparent earnings by $100K–$400K, moving enterprise value by $500K–$3M at a 7x multiple.[6][10]
Earnings basis
SDE or EBITDA? It depends on your size
The most consequential framing question for any dental practice owner is which earnings metric applies to your practice — and it changes entirely with size and ownership structure. A solo owner-dependent practice is priced on SDE or a percentage of annual collections; a multi-provider group with associate-led production is priced on associate-adjusted EBITDA. Conflating the two is the single most common valuation error dental owners make.[6][9] DSO affiliation has accelerated consolidation: per the ADA Health Policy Institute, DSO affiliation reached 16.1% of US dentists in 2024, more than doubling since 2015 — making the DSO buyer pool larger and more competitive than at any prior point.[4]
| Business size | Priced on | Typical multiple | What's going on |
|---|---|---|---|
| Under ~$2M value (small/solo) | % of collections / SDE | 60%–80% of collections; ~1.6x–3.0x SDE | Solo owner-dependent practice; buyer pool is individual dentists or SBA-financed buyers; DSOs rarely engage below $250K post-doctor-comp EBITDA. DealStats 2024 reported MVIC/SDE of 2.68x and MVIC/Sales of 0.66x (11 transactions, directional only).[11][12] |
| $2M – $10M EV (DSO add-on) | Associate-adjusted EBITDA | 5x – 8x | Multi-provider or early associate-led practice; DSO add-on candidates; reduced owner dependence unlocks EBITDA-based pricing. Hygiene mix and payor profile set the range within the band. Healthy general dental overhead runs ~60%–65% of collections; normalized associate-adjusted EBITDA margin typically runs 18%–28%.[5][1][9] |
| $10M – $50M EV (regional platform) | Associate-adjusted EBITDA | 9x – 11x | Multi-site clusters with centralized billing and management; platform-grade governance attracts PE-backed DSOs; competitive LOI processes common at $1M+ EBITDA.[1][9][2] |
| $50M+ EV (large platform / recap) | Associate-adjusted EBITDA | 10x – 12x+ | DSO-to-DSO M&A and sponsor recapitalizations; large-platform multiples reset from a 2021 peak of ~13–16x to ~9–10x per Colao/Dykema; specialty platforms (ortho, OMS) can exceed 12x.[7][2] |
Per the IBBA/M&A Source market-pulse framing, businesses valued under ~$2M are priced on SDE (which adds back the owner's full compensation); those valued above ~$2M are priced on adjusted EBITDA (which subtracts a market-rate replacement manager's salary). In dental, this pivot is compounded by the associate adjustment: before computing EBITDA the owner-dentist's clinical production must be replaced at a market clinical wage — roughly 25–35% of their personal production — or the resulting EBITDA figure is really total owner benefit, not transferable earnings.[6][10][3]
Interactive estimate
Estimate what your dental practice is worth
Move the sliders. The range reflects how each driver pushes the multiple up or down for a dental practice. Treat it as a planning anchor — not a formal valuation.
Platform-grade groups (3+ locations, shared billing/management) trade at 9–11x vs add-on single-site practices at 5–8x. Single-location practices cap at the add-on band regardless of EBITDA quality.
The single highest-leverage variable. Practices where the owner produces 90%+ of revenue face a 10–20% valuation reduction. Associate-led production unlocks competitive DSO processes and reduces earn-out risk.
Commercial/FFS-heavy mix supports premium pricing. Heavy Medicaid/HMO concentration is a state-level underwriting variable for DSO acquirers and can compress the multiple by 0.5–1.0x.
A dense hygiene schedule signals a stable, transferable patient base. DSO buyers underwrite forward cash flow on the assumption the hygiene base survives the selling dentist's exit. Sources tie hygiene above 28–33% of collections to premium multiples and better DSO offers.
Estimated enterprise value
$7.2M – $11.1M
Implied multiple: 5.5x – 8.5x Adjusted EBITDA
Illustrative planning range only, based on typical dental EBITDA multiples and driver sensitivities — not a formal valuation or an offer.
Methodology
The three ways a dental practice gets valued
A credible valuation triangulates across all three. Any single number in isolation is suspect.
Market approach — comparable dental transactions
The default for any healthy dental groupThe market approach values your practice against actual sale prices and EBITDA multiples of comparable dental transactions. It dominates dental M&A because the DSO buyer pool has created an unusually rich private comp set: FOCUS Investment Banking, Sorso, Large Practice Sales, and PrivSource publish DSO add-on and platform ranges updated annually, giving buyers and advisors real transaction evidence rather than generic benchmarks.[1][2][9]
The comp set must be segmented on two axes: size band (sub-$500K EBITDA, $1–3M, and $3M+ are structurally different buyer pools with different price ranges) and practice type (general dentistry vs. specialty — ortho, OMS, perio, and endo carry distinct premiums). Adjustments for service area demographics, payor mix, and competition density then move the indicated multiple within the band.[1][2]
Income approach — normalized cash-flow or DCF model
Associate-adjustment cross-check and hygiene-stream modelingIn dental valuation the income approach is useful primarily as a cross-check on the associate adjustment and as a way to value the recurring hygiene stream separately from production. The defining normalization is replacing the owner-dentist's clinical compensation with a market rate — typically 25–35% of their personal production for a GP — before computing EBITDA. Skipping this step means the resulting figure is total owner benefit, not transferable earnings, and the DCF overstates value.[6][10]
For larger LMM groups, a 5-year forecast with explicit modeling of hygiene-to-restorative conversion, new-patient flow, and associate compensation at market collection rates provides a useful sanity check against the market approach. The income approach carries more weight for multi-location groups with predictable production and stable associate retention.[1]
Asset approach — adjusted net asset value and goodwill floor
Floor check and tax-allocation planningFor a healthy dental practice, the asset approach almost never drives the headline value — 80–85% of practice value is intangible goodwill, and the operating value of a cash-flowing multi-provider group is a multiple of its tangible asset base.[1] The asset approach is used as a sanity-check floor: if the sum of chairs, CBCT, CAD-CAM, leasehold improvements, and patient-list intangibles approaches operating value, EBITDA quality is likely overstated or the associate adjustment was omitted.
The asset approach matters most for tax-allocation planning. Goodwill is taxed at long-term capital gains rates (20% + 3.8% NIIT), while equipment and non-compete payments are taxed at ordinary income rates. Negotiating the purchase-price allocation at LOI — keeping goodwill as large as is defensible — is one of the highest-value pre-close planning steps for a dental seller.[10]
Value drivers
What moves the multiple for a dental practice
DSO-readiness / multi-location scale
+2x to +4x platform premiumThe biggest single lift in dental M&A is the jump from DSO add-on pricing to platform pricing. Platform-grade groups (3+ locations, shared management and billing infrastructure) trade at 9–11x EBITDA versus add-on single-site practices at 5–8x — a spread of 2–4 turns on the same underlying earnings.[1][2] Moving from one location to a regional cluster is not merely an operational choice; it restructures the buyer pool from small add-on buyers to PE-backed DSO platforms running a competitive LOI process, which is the mechanism that actually converts benchmark multiples into premium ones.[9]
Associate-driven production (low owner dependence)
+0.5x to +1.5xWhen the owner-dentist produces less than 60–70% of clinical revenue, the DSO can underwrite future cash flows without the seller — key-person risk falls, earn-out exposure shrinks, and the buyer pool widens. Practices where the owner performs 90%+ of production face valuation reductions of approximately 10–20%, per Sofer Advisors cited by FOCUS Investment Banking.[9][1] In 2026, provider transferability has moved from a background consideration to a primary DSO underwriting variable.[7]
Strong hygiene and recare base
+0.5x to +1.0xA hygiene base above 28–33% of collections is a strong signal of patient-base stability and recurring cash flow that survives a selling-dentist transition. DSO buyers underwrite forward revenue on the assumption the hygiene schedule continues running; a dense recare base — high 6-month recall compliance, strong hygiene-to-restorative conversion — supports the upper end of the applicable size-band multiple.[1][6]
Commercial PPO/FFS-heavy payor mix
+0.5xA commercial or fee-for-service-heavy payor mix signals lower reimbursement volatility and faster close timelines. FFS-heavy practices average roughly 1.1–1.3x revenue value versus ~0.7–0.9x for PPO-heavy practices; the FFS premium on value runs approximately 15–25%.[14] Commercial/PPO-heavy practices also avoid the state-level Medicaid policy underwriting risk that has lengthened diligence timelines for practices with high public-payor concentration.[7]
Single owner-dependent provider (owner produces 90%+ of revenue)
−10% to −20% of valueOwner dependence is the most common and most preventable discount in dental M&A. When the selling dentist is the primary clinician, buyers cannot underwrite the production revenue that walks out the door at close — and respond with a lower headline multiple, a larger earn-out, or both.[9][1] The DSO buyer pool also shrinks to add-on buyers rather than competitive platforms, eliminating the auction dynamic that generates premium pricing. Eighteen to twenty-four months of associate build-out before a planned sale is the clearest path to escaping this discount.
Heavy Medicaid/HMO payor concentration
−0.5x to −1.0xPractices with 40%+ of collections from Medicaid or HMO/capitation plans face multiple compression of 0.5–1.0x as DSO buyers model reimbursement-rate risk, managed-care re-credentialing complexity, and state-policy change exposure post-close.[7][14] In 2026, state Medicaid policy has become a formal underwriting variable in DSO diligence — acquirers are benchmarking state dental Medicaid legislation alongside practice P&Ls before submitting LOIs. The discount is especially pronounced in states with contested Medicaid dental benefit changes.
Sub-$500K EBITDA / sub-DSO scale
Caps at ~3x – 5x EBITDABelow approximately $500K associate-adjusted EBITDA the buyer pool collapses to individual dentists and SBA-financed buyers. DSO and IDSO platforms typically do not engage below $250K post-doctor-comp EBITDA, and without multiple competitive bidders there is no auction dynamic — no auction means no platform multiple.[10] Practices below $1.5M in collections typically transact on a collections percentage or SDE basis, with DealStats 2024 reporting a median MVIC/SDE of 2.68x across 11 transactions — a directional benchmark from a small, geographically skewed sample.[11]
Deferred technology capex and aging operatories
−0.25x to −0.5xDSO acquirers normalize the post-close equipment upgrade cost against purchase price. Aging operatories without cone-beam CT, no digital impressions, paper charts, and outdated sterilization equipment signal a $100K–$500K capex liability that buyers deduct from enterprise value in their models.[2] A modern, fully digital workflow removes this discount. In specialty practices — ortho, OMS — up-to-date imaging technology is effectively non-negotiable for top-quartile multiples.[2]
Worked example
A $6M-revenue dental group, step by step
An illustrative multi-location general dentistry group with two associates, the owner producing roughly 20% of clinical revenue, and a hygiene base at 32% of collections. Numbers are illustrative, not a specific practice.
Annual collections / revenue
$6.0M
Multi-location group, owner + two full-time associates; hygiene ~32% of collections
Associate-adjusted EBITDA
$1.32M
≈22% margin after full associate-compensation normalization: owner produces ~$1.2M personally; market clinical wage at ~30% of production = −$360K replacement cost deducted before EBITDA is computed.[6][10]
Applied multiple
7.0x
Mid-range for a clean $1.3M-EBITDA multi-provider group with associate-led production and strong hygiene mix.[1][9]
Enterprise value
≈ $9.2M
Associate-adjusted EBITDA × multiple ($1.32M × 7.0x)
Indicative result
≈ $9.2M enterprise value
The associate adjustment is the highest-leverage number in the exercise. Without it, the same P&L would show ~$1.68M in apparent EBITDA (owner benefit not normalized to market wage) — at 7.0x that is a $11.8M implied value, a ~$2.5M overstatement driven entirely by a missing line item.[6][10] At the other end: if the owner still produces 85% of collections and the group has a single location, a DSO buyer would price this at a lower add-on multiple of ~5.5x, producing ≈ $7.3M — demonstrating how provider dependence and single-site scale compress value even with identical revenue. This is illustrative, not an offer or a formal valuation.
Cost & who does it
What a dental practice valuation costs — and who should do it
Before you engage any buyer, your first priority is a defensible associate-adjusted EBITDA documented across at least three years. The right tool depends on what you need and when you need it.
Broker / advisor opinion of value
Free – $5,000
Best for
Testing the market, setting a realistic listing range, annual tracking
Fast; not certified and not accepted by the IRS or courts. Dental-specialist M&A advisors frequently provide a preliminary estimate free to win an engagement.
Formal certified appraisal (USPAP)
$1,500 – $8,000+
Best for
Estate or gift tax, ESOP, partner buyout, SBA, litigation
A solo-practice formal appraisal typically runs $1,500–$3,500; broader multi-entity or multi-location group engagements run $2,500–$8,000+ and up to ~$25,000 for complex litigation or estate purposes. Performed by a credentialed appraiser (CVA / ABV / ASA); defensible to the IRS and courts.[16][15]
Quality of earnings (QoE)
$15,000 – $75,000+
Best for
Validating associate-adjusted EBITDA before going to market with a DSO
Not an audit; tests every add-back including the associate adjustment, working capital, and payor-mix normalization. Often pays for itself by preventing a DSO re-trade in diligence. Sub-$3M EBITDA engagements typically run $15K–$25K; $3M–$10M run $25K–$50K.[15][17]
For most $5M–$200M dental practice owners the right sequence is: an advisor opinion of value to orient and pressure-test the associate adjustment; a sell-side QoE to validate and document adjusted EBITDA before any DSO sees your financials; and a certified appraisal only if an estate, gift-tax, ESOP, or litigation trigger requires it. A dental-specific QoE that explicitly models the owner-doctor normalization is especially high-leverage — DSO quality-of-earnings teams will run their own version in diligence regardless, and an undocumented add-back is the fastest way to lose ground in re-trade negotiations.[6][10][18] With Ad Astra's verified $1B+ in closed transaction value and Axial Top 25 recognition, a confidential opinion of value is a no-obligation place to start — book a confidential call.
Before you sell
How to increase your valuation before going to market
The gap between a 5x owner-dependent single-site practice and a 9x+ platform-ready group is built over 18–36 months, not negotiated in a letter of intent. Our value enhancement work is designed around the levers below.
Hire and develop associates to de-risk owner dependence
+0.5x to +2.0x — and reclassifies pricing from SDE to EBITDAAdding a full-time associate at least 18–24 months before a planned sale is the single highest-return pre-sale investment in dental M&A. Reducing the owner-dentist below 60–70% of production removes the 10–20% owner-dependency discount, shifts the practice from SDE/collections pricing to an EBITDA-multiple basis, and narrows or eliminates the earn-out clause — all of which expand both the headline multiple and the share of consideration received as cash at close.[9][1][20] Document associate production trends over at least two fiscal years to make the trajectory credible in diligence.
Shift payor mix toward FFS and commercial PPO
+0.5x to +1.5x on valueSelectively terminating the lowest-paying PPO contracts and converting those patients to a fee-for-service or direct-membership schedule can lift EBITDA margins by several points and raise the practice's multiple simultaneously. FFS-heavy practices command a 15–25% premium on value versus comparable PPO-heavy peers.[14] Run the payor-by-payor contribution margin before dropping contracts and model the net-patient retention with your front-desk team before executing.
Build hygiene density and recare infrastructure
+0.5x to +1.0xA hygiene base above 30% of collections is a DSO valuation signal, not just a clinical metric. Invest in automated recall, hygiene-to-restorative conversion training, and a second hygiene operatory if your schedule is full. DSO buyers specifically look at hygiene reappointment rate, 6-month recall compliance, and the hygiene-to-restorative conversion rate in diligence — a practice that can document improvement in all three, with 18 months of trend data, earns the upper end of the add-on band multiple.[1][6]
Add locations to reach platform pricing
+2x to +4x — moves from add-on to platform buyer poolMoving from one location to a cluster of three or more — with shared billing staff, a group office manager, and centralized credentialing — transitions the practice from a DSO add-on candidate (5–8x) to an emerging-platform candidate (9–11x). This is a 2–4 turn improvement on the same EBITDA dollar for a multiple. A $1.3M-EBITDA group earning 7x is a $9.2M business; the same EBITDA at 10x is $13M. The delta is not EBITDA growth — it is buyer pool expansion.[1][2]
Modernize technology and resolve deferred capex
+0.25x to +0.5x — removes the deferred-capex EV deductionAging operatories, paper charts, and missing CBCT or CAD-CAM technology signal a $100K–$500K post-close upgrade cost that DSO buyers deduct from enterprise value in their models.[2] Investing in a digital workflow before going to market removes this negotiating lever from the buyer, particularly for specialty practices where up-to-date imaging is non-negotiable for top-quartile pricing.
FAQ
Common questions about dental practice valuation
Go deeper on dental practice multiples
Value another business
From estimate to real number
Get an owner-grade valuation of your dental practice
A confidential 30-minute call with Clayton or Joe gives you a real range, the adjustments we'd apply to your reported earnings, and the one or two moves that close the gap fastest — built on healthcare services & it deal data.
- [1] FOCUS Investment Banking — Dental Practice Valuation for 2026
- [2] Sorso — Dental Practice EBITDA Multiple 2026 (5x–12x by size)
- [3] IBBA & M&A Source — Market Pulse Q3 2025 Highlights (PDF)
- [4] ADA Health Policy Institute — The U.S. Dentist Workforce (DSO affiliation 16.1% in 2024)
- [5] Sorso — Dental Practice Profit Margin (2026 Benchmark)
- [6] TUSK Practice Sales — Checklist for Calculating Dental Practice EBITDA
- [7] Group Dentistry Now — Navigating the DSO M&A Market in 2026 (Brian Colao, Dykema)
- [8] IBISWorld — Dentists in the US Industry Analysis 2026
- [9] FOCUS Investment Banking — Dental Practice EBITDA Multiples 2026
- [10] Large Practice Sales — How Much Do Dental Practices Sell For?
- [11] Adams Brown CPA — How Can I Determine the Value of My Dental Practice? (DealStats data)
- [12] US Dental Practices — What is Your Dental Practice Worth? (avg 72% of collections)
- [13] Wipfli — Are business valuation online calculators accurate?
- [14] Scott Leune — Dental Practice Valuation: Why Values Differ (FFS vs PPO premium)
- [15] ROI Corporation — How Much is Your Practice Worth? (appraisal cost)
- [16] Peak Business Valuation — Valuation Multiples for a Dental Practice
- [17] CT Acquisitions — Quality of Earnings (QoE) Report: 2026 Guide
- [18] Large Practice Sales — Understanding and Improving Dental Practice EBITDA
- [19] Vertess — How to Value a Dental Practice
- [20] Large Practice Sales — Maximizing a Practice's Value for an IDSO Partnership
Ranges represent typical lower middle market transactions; individual deals may fall outside the band based on buyer thesis, deal structure, and company-specific factors. This page is informational and not a formal valuation opinion.